RESUMEN
Acute exacerbations, most of which are due to lower respiratory tract infections, cause great morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD) and most of these are due to lower respiratory tract infections. The aim of this study was to determine the causative organism and the effects of azithromycin, ampicillin sulbactam (sultamicillin), ciprofloxacin and cefaclor monohydrate therapy in COPD. One hundred and six patients with COPD in acute exacerbation were randomized into four groups for empiric antibiotic treatment following lung function tests and sputum examination. The most common strains isolated from sputum were Haemophilus influenzae (30.8%), Streptoccocus pneumoniae (12%) and Moraxella catarrhalis (7.7%). Azithromycin, sultamicillin, ciprofloxacin and cefaclor monohydrate were found to be effective in treating COPD exacerbations.
Asunto(s)
Antiinfecciosos/uso terapéutico , Enfermedades Pulmonares Obstructivas/tratamiento farmacológico , Ampicilina/uso terapéutico , Azitromicina/uso terapéutico , Cefaclor/uso terapéutico , Ciprofloxacina/uso terapéutico , Quimioterapia Combinada/uso terapéutico , Femenino , Humanos , Enfermedades Pulmonares Obstructivas/microbiología , Masculino , Persona de Mediana Edad , Sulbactam/uso terapéutico , Resultado del TratamientoRESUMEN
Poly(d,l)-lactide (PDLLA) homopolymer, with an average molecular weight of 20,000 daltons, was produced by the ring-opening polymerization of d,l-lactide in the presence of SnCl(2).2H(2)O as the catalyst. The PDLLA sponges loaded with chloramphenicol were prepared by a solvent evaporation technique. The drug loadings achieved were 14.84 and 25.23 mg for the PDLLA sponges with 35 and 70 mg total weights, respectively. These sponges were implanted in Wistar rats, and in vivo degradation, drug release, and tissue reactions were followed. The PDLLA sponges carrying no drug degraded with time linearly. Almost 80% of the sponges were degraded in about 180 days. While the drug-loaded PDLLA sponges were degraded much faster in 4 weeks (about 35% of the matrix was degraded), then the degradation slowed down significantly. Drug release from the sponges was parallel to the degradation. Almost 60% of the loaded drug released in 4 weeks. There were no acute inflammatory reactions in the initial period, either for the plain or for the drug-loaded PDLLA sponges. Macrophages and multinuclear giant cells start to appear after 7 days of implantation. The fibroblastic activity also started after the same period. After that, there were decreases in the number of some cells (neutrophils, lymphocytes, and macrophages), while multinuclear giant cells and fibroblastic activities gradually increased. Granulation tissue started at about 1 month, and new connective tissue was gradually formed until 180 days of implantation. There were significant numbers of inflammatory cells after 60 days, which were replaced by fibroblasts after 180 days. There was almost no significant neovascularization after 180 days, but implant fragmentation gradually increased (which slows the degradation) with time. It was concluded that this novel drug release sponge may be safely and effectively used as an active soft tissue-filling material.
Asunto(s)
Cloranfenicol/farmacocinética , Poliésteres/farmacocinética , Prótesis e Implantes , Traumatismos de los Tejidos Blandos/cirugía , Tapones Quirúrgicos de Gaza , Cicatrización de Heridas , Animales , Cloranfenicol/administración & dosificación , Tejido Conectivo/patología , Implantes de Medicamentos/efectos adversos , Estudios de Evaluación como Asunto , Reacción a Cuerpo Extraño/etiología , Reacción a Cuerpo Extraño/patología , Tejido de Granulación/patología , Leucocitos/patología , Macrófagos/patología , Masculino , Peso Molecular , Poliésteres/química , Prótesis e Implantes/efectos adversos , Ratas , Ratas Wistar , Tapones Quirúrgicos de Gaza/efectos adversos , Infección de la Herida Quirúrgica/prevención & controlRESUMEN
Thirty-one patients with the diagnosis of thyroid associated eye disease were included in the study. Samples were obtained from upper and temporal bulbar conjunctiva of both eyes by cellulose acetate filter paper. Control group included 20 healthy individuals. In patients with thyroid associated eye disease, grade 2 or 3 squamous metaplasia was observed in 32.26% of the samples obtained from upper bulbar conjunctiva, whereas this ratio increased to 82.26% in temporal bulbar area. None of the control cases showed changes of grade 2 or more. The evaluation of cytological changes with respect to clinical findings revealed that the main factor responsible for the cytological findings was inflammatory changes of the conjunctiva, whereas interpalpebral distance and proptosis had only a partial effect.